INDICATION: SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use (CIII) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for at least 7 days. SUBLOCADE is part of a complete treatment plan that should include counseling.

Opioid Addiction
IS A CHRONIC DISEASE

Opioid addiction is a disease that involves compulsive drug-seeking, even when there may be negative consequences. It's not a moral weakness. It's a chronic disease in which people develop a pattern of using opioids that can lead to clinically significant impairment or distress. Some of the most commonly abused opioids include hydrocodone, oxycodone, codeine, and heroin.

Opioid addiction Opioid addiction
Individuals depicted are models used for illustrative purposes only.

Opioid addiction is sometimes known as Opioid Use Disorder (OUD).
OUD can vary in severity.

The effect of opioid addiciton on the brain

THE EFFECT OF OPIOID
ADDICTION ON THE BRAIN

Regions of the brain that control reward, decision-making, impulse control, learning, and other functions may be affected in people with opioid addiction. Because of the effects of opioids on the brain over time for some people with opioid addiction, choosing whether to take opioids may be out of a person's control.

Did you know?

DID YOU KNOW?

Developmental, environmental, social, and genetic factors can play a role in determining whether or not someone develops opioid addiction.

The Opioid Epidemic

There is an opioid epidemic in the United States.
If you're worried you might have a problem, you're not alone.

Based on survey results, in 2016 an estimated:

Opioid addiction statistics
Opioid addiction statistics

*Substance Abuse and Mental Health Services Administration (SAMHSA) (2017). Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. People surveyed were age 12 and older.

It is not known if SUBLOCADE is safe or effective in children. Buprenorphine can cause severe, possibly fatal, respiratory depression in children who are accidentally exposed to it.

Did you know?

DID YOU KNOW?

Opioid addiction can vary in severity.

HOW DO I KNOW IF I HAVE OPIOID ADDICTION?

A variety of symptoms are associated with opioid addiction. Symptoms of opioid addiction may include a strong desire for opioids, an inability to control or reduce use, continued use despite interference with major obligations or social functioning, use of larger amounts over time, development of tolerance, spending a great deal of time obtaining and using opioids, and withdrawal symptoms that occur after stopping or reducing use, such as negative mood, nausea or vomiting, muscle aches, diarrhea, fever, and insomnia.

If you think you have a problem, the only person who can diagnose you is a healthcare provider. There are healthcare providers and treatment options that may be able to help.

Individuals depicted are models used for illustrative purposes only.

CONCERNED ABOUT YOUR CONDITION?

While opioid addiction has no cure, there's treatment that can help. One type of treatment involves medication and counseling. This approach may help manage various aspects of the condition.

Talk to a healthcare provider—you can use this SUBLOCADE Treatment Discussion Guide to help prepare for questions your healthcare provider may ask and to take notes at your appointment.

If you need help finding a treatment provider, you can use our Find a Treatment Provider Locator or you can visit the Substance Abuse and Mental Health Services Administration (SAMHSA) website.

Receive more information.

Important Safety Information

What is the most important information I should know about SUBLOCADE?

Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.

  • SUBLOCADE is not available in retail pharmacies.
  • Your SUBLOCADE injection will only be given to you by a certified healthcare provider.

INDICATION

SUBLOCADE™ (buprenorphine extended-release) injection, for subcutaneous use (CIII) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for at least 7 days. SUBLOCADE is part of a complete treatment plan that should include counseling.

In an emergency, you or your family should tell the emergency medical staff that you are physically dependent on an opioid and are being treated with SUBLOCADE.

Buprenorphine, the medicine in SUBLOCADE, can cause serious and life-threatening problems, especially if you take or use certain other medicines or drugs. Call your healthcare provider right away or get emergency help if you:

  • feel faint or dizzy
  • have mental changes such as confusion
  • have slower breathing than you normally have
  • have severe sleepiness
  • have blurred vision
  • have problems with coordination
  • have slurred speech
  • cannot think well or clearly
  • have a high body temperature
  • have slowed reflexes
  • feel agitated
  • have stiff muscles
  • have trouble walking

These can be signs of an overdose or other serious problems.

Death or serious harm, including life-threatening breathing problems, can happen if you take anxiety medicines or benzodiazepines, sleeping pills, tranquilizers, muscle relaxants, or sedatives, antidepressants, or antihistamines, or drink alcohol during treatment with SUBLOCADE. Tell your healthcare provider if you are taking any of these medicines and if you drink alcohol.

SUBLOCADE is a controlled substance (CIII) because it contains buprenorphine that can be a target for people who abuse prescription medicines or street drugs.

Death has been reported in those who are not opioid dependent who received buprenorphine sublingually.

Do not use SUBLOCADE if you are allergic to buprenorphine or any ingredient in the prefilled syringe (ATRIGEL® Delivery System, a biodegradable 50:50 poly(DL-lactide-co-glycolide) polymer and a biocompatible solvent, N-methyl-2-pyrrolidone (NMP)).

SUBLOCADE may not be right for you. Before starting SUBLOCADE, tell your healthcare provider about all of your medical conditions, including:

  • Trouble breathing or lung problems
  • An enlarged prostate gland (men)
  • A head injury or brain problem
  • Problems urinating
  • A curve in your spine that affects your breathing (scoliosis)
  • Liver problems
  • Gallbladder problems
  • Adrenal gland problems
  • Addison’s disease
  • Low thyroid hormone levels (hypothyroidism)
  • A history of alcoholism
  • Mental problems such as hallucinations (seeing or hearing things that are not there).
  • Are pregnant or plan to become pregnant. Opioid-dependent women on buprenorphine maintenance therapy may require additional analgesia during labor. If you receive SUBLOCADE while pregnant, your baby may have symptoms of opioid withdrawal at birth.
  • Are breastfeeding or plan to breastfeed. SUBLOCADE can pass into your breast milk and may harm your baby. Talk with your healthcare provider about the best way to feed your baby during treatment with SUBLOCADE. Watch your baby for increased drowsiness and breathing problems.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. SUBLOCADE may affect the way other medicines work and other medicines may affect how SUBLOCADE works. Some medicines may cause serious or life-threatening medical problems when taken with SUBLOCADE. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist each time you get a new medicine.

The doses of certain medicines may need to be changed if used during treatment with SUBLOCADE. Do not take any medicine during treatment with SUBLOCADE until you have talked with your healthcare provider. Your healthcare provider will tell you if it is safe to take other medicines during treatment with SUBLOCADE.

You should not take anxiety medicines or benzodiazepines (such as Valium® or Xanax®), sleeping pills, tranquilizers, muscle relaxants, or sedatives (such as Ambien®), antidepressants, or antihistamines that are not prescribed to you during treatment with SUBLOCADE, as this can lead to slowed breathing, drowsiness, delayed reaction time, loss of consciousness or even death. If a healthcare provider is considering prescribing such a medicine for you, remind the healthcare provider that you are being treated with SUBLOCADE.

You may have detectable levels of SUBLOCADE in your body for a long period after stopping treatment with SUBLOCADE.

What should I avoid while being treated with SUBLOCADE?

  • Do not drive, operate heavy machinery, or perform any other dangerous activities until you know how this medicine affects you. Buprenorphine can cause drowsiness and slow reaction times. This may happen more often in the first few days after your injection and when your dose is changed.
  • Do not drink alcohol during treatment with SUBLOCADE, as this can lead to slowed breathing, drowsiness, slow reaction time, loss of consciousness or even death.

What are the possible side effects of SUBLOCADE?

SUBLOCADE can cause serious side effects, including:

  • Physical dependence and withdrawal. Your body can develop a physical need for SUBLOCADE (dependence). If you stop receiving SUBLOCADE, you could have opioid withdrawal symptoms such as:
    • shaking, goose bumps, muscle aches
    • sweating more than normal
    • feeling hot or cold more than normal
    • runny nose and watery eyes
    • diarrhea or vomiting

    These symptoms may start weeks to months after your last dose of SUBLOCADE.

  • Liver problems. Call your healthcare provider right away if you notice any of these signs of liver problems:
    • your skin or the white part of your eyes turns yellow (jaundice)
    • urine turns dark
    • bowel movements (stools) turn light in color
    • decreased appetite
    • stomach (abdomen) pain or nausea

    Your healthcare provider may do tests before and during treatment with SUBLOCADE to check your liver.

  • Allergic reaction. Call your healthcare provider or get emergency help right away if you get:
    • rash, hives, itching
    • swelling of your face
    • wheezing
    • dizziness, or a decrease in consciousness
  • Decrease in blood pressure. You may feel dizzy when you get up from sitting or lying down.
  • The most common side effects of SUBLOCADE include:
    • constipation
    • headache
    • nausea
    • injection site itching
    • vomiting
    • increase in liver enzymes
    • tiredness
    • injection site pain
  • Long-term (chronic) use of opioids, including SUBLOCADE, may cause fertility problems in males and females. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects. Call your healthcare provider for medical advice about side effects.

To report pregnancy or side effects associated with taking SUBLOCADE, please call 1-877-782-6966. You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information about SUBLOCADE, see the full Prescribing Information including BOXED WARNING, and Medication Guide or talk to your healthcare provider. For REMS information visit www.sublocadeREMS.com.

You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.